Health Care·Health Care Equipment·$12.9B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.22 | N/A | +2.07% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.22 | N/A | +2.07% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a sense of cautious optimism regarding future prospects. They acknowledged current market challenges but emphasized their commitment to innovation.
Management highlighted ongoing product development efforts.
They noted challenges in the market but expressed confidence in long-term growth.
Penumbra Inc's earnings report shows a slight beat on EPS, indicating some positive momentum. However, the stock fell 4.4% in reaction, likely due to a lack of revenue data and no guidance for future performance. Investors may be concerned about market challenges mentioned by management.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ONEOK INC NEW
Feb 24, 2020